The emerging treatment of this peptide represents a exciting advance in the care of diabetes mellitus type 2. Different to existing medications, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide097976.blogproducer.com/49847859/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment